We’re excited to join the lupus community at the fifth annual Lupus Research Alliance Lupus Clinical Investigators Network (LuCIN) Community Meeting for exchange on the latest in lupus clinical research and advancements being made for patients. ? Learn more about our progress for patients with #autoimmune diseases including lupus:?https://bit.ly/3XJgnEJ ? #LuCINCommunity #LupusTherapeutics
Cullinan Therapeutics
生物技术研究
Cambridge，Massachusetts 9,331 位关注者
Modality-Agnostic Targeted Therapeutics
关于我们
Cullinan Therapeutics is dedicated to creating new standards of care for patients. We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class. Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications. Notice to Job Seekers: Job applicants should be aware of job recruitment, interview and offer scams being perpetrated through the use of the internet and social media platforms. To learn more, visit our Careers page or read Cullinan’s Employment Recruitment Scams Notice here: https://cullinantherapeutics.com/docs/employment-recruitment-scams-notice.pdf
- 网站
-
https://www.cullinantherapeutics.com
Cullinan Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Cambridge，Massachusetts
- 类型
- 上市公司
- 领域
- Oncology和Auto-Immune Diseases
地点
-
主要
获取路线
1 Main St
US，Massachusetts，Cambridge，02142
Cullinan Therapeutics员工
动态
-
We’re proud to congratulate Yue Zhang, Senior Director, Clinical Research Scientist, for being recognized as a 2025 Rising Star by the Healthcare Businesswomen’s Association. Yue embodies what we stand for at Cullinan with her deep commitment to developing medicines that will have a meaningful impact for patients. Join us in celebrating Yue and this well-deserved achievement! Learn more: https://bit.ly/4hOgDK2 #HBAimpact #HBAWOTY25
-
-
There continues to be a significant unmet need for safe and effective therapies targeting EGFRex20ins mutations in non-small cell lung cancer (#NSCLC).? ? In partnership with Taiho Pharmaceutical and Taiho Oncology, Inc., we are researching zipalertinib as a potential therapeutic option for this subtype of NSCLC. Learn more: https://bit.ly/42xaCgL
-
-
#MultipleMyeloma is a rare blood cancer affecting plasma cells in the bone marrow. It also has one of the largest racial disparities in cancer prevalence and mortality rate.? ? We are working to advance novel treatments that may help overcome immune evasion mechanisms employed by tumors in multiple myeloma, along with other cancers.? ? #MyelomaActionMonth
-
-
What does #WomensHistoryMonth mean to you? Read through our team’s reflections on the significance of this day for the women of yesterday, today, and the future.
-
Our President and CEO, Nadim Ahmed, and Chief Medical Officer, Jeff Jones, recently participated in fireside chats at the TD Cowen 45th Annual Healthcare Conference and the Leerink Partners Global Healthcare Conference. Listen to the discussions: https://bit.ly/40NCzyr
-
-
T cell engagers are fueling innovation in the #autoimmune therapeutic landscape as an approach that has high therapeutic potential to deliver deep and durable B cell depletion.? ? Learn more about our CD19-directed T cell engager being investigated in an effort to create new standards of care for patients with autoimmune diseases. https://bit.ly/43iW18V?
-
-
At Cullinan, we all bring a diverse background of perspectives, but we share a common goal: pioneering novel therapies. In recognition of International Women’s Day, we asked women at Cullinan what they would say to any young woman considering a #STEM career.?? ? #AccelerateAction? #IWD2025?
-
In honor of International Women’s Day tomorrow, we’re sharing our team’s perspectives on empowering women for success in the workplace. Swipe through to see some of their responses.? ? Through programs such as our We-GEM Cullinan Community (employee resource group), we commit to #AccelerateAction for full gender equality.? ? #IWD2025?
-
Did you know that dysregulation of the immune system’s precise balance can lead to serious health conditions, like #autoimmune diseases and cancer? Cullinan’s unique scientific approach aims to restore immune balance by targeting and harnessing key mechanisms of immune modulation.? ? Watch and learn more: https://bit.ly/40dEUlZ?